January 22, 2022

SEC accuses Biotech VC of siphoning funds

Pin It

By Ross Todd, From The Recorder SAN FRANCISCO — Prominent biotech venture capitalist G. Steven Burrill has agreed to pay nearly $5.8 million to settle charges that he redirected money from one of his funds to prop up other flagging investments and to pay for his luxurious lifestyle. The Securities and Exchange Commission alleged that Burrill […]